iodine I 131: Clinical Trials

4 trials of iodine I 131, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 1 terminated. 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 2, Terminated 1
Phase 21Completed 1

Follow iodine I 131: new trials by email Literature Review of iodine I 131 trials Research Report on iodine I 131

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Iodine I 131 and Pazopanib Hydrochloride in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer Previously Treated With Iodine I 131 That Cannot Be Removed By Surgery
pazopanib hydrochloride, iodine I 131 - Recurrent Thyroid Cancer, Stage IVA Follicular Thyroid Cancer
Phase 1CompletedUniversity of Washington62011-12-012015-11-05
Gene Therapy and Radioactive Iodine in Treating Patients With Locally Recurrent Prostate Cancer That Did Not Respond to Radiation Therapy
Ad5-CMV-NIS, Liothyronine Sodium, Reverse Transcriptase Polymerase Chain Reaction - Prostate Cancer
Phase 1TerminatedMayo Clinic82008-11-032026-07-22
Decitabine in Treating Patients With Metastatic Papillary Thyroid Cancer or Follicular Thyroid Cancer Unresponsive to Iodine I 131
Decitabine, Iodine I 131, Recombinant thyrotropin alfa - Recurrent Thyroid Cancer, Stage IVA Follicular Thyroid Cancer
Phase 2CompletedNational Cancer Institute (NCI)122004-05-012018-11-29
Azacitidine to Restore Thyroid Function in Patients With Persistent or Metastatic Thyroid Cancer
azacitidine, liothyronine sodium, iodine I 131 - Head and Neck Cancer
Phase 1CompletedLucille P. Markey Cancer Center at University of Kentucky1999-07-012013-12-19

Conditions studied

Adenocarcinoma, Follicular (3)  ·  Thyroid Cancer, Papillary (3)  ·  Thyroid Neoplasms (3)  ·  Head and Neck Neoplasms (1)  ·  Prostatic Neoplasms (1)

Sponsors

Lucille P. Markey Cancer Center at University of Kentucky (1)  ·  Mayo Clinic (1)  ·  National Cancer Institute (NCI) (1)  ·  University of Washington (1)

Countries

United States (4)

Top investigators

Brian J. Davis, M.D. (1)  ·  Kenneth Ain, MD (1)  ·  Laura Chow (1)  ·  Steven Sherman (1)

Results publications

PMID 28662033

NIH funding

N01CM62207 (1), P30CA015704 (1), P30CA016672 (1), P50CA091956 (1)